Real-world comparative effectiveness and safety of FLT3 inhibitors combined with induction chemotherapy in acute myeloid leukemia Read more
STML-401-0423 A Phase II Multicenter Open-Label Trial of Tagraxofusp (TAG) in Combination with Venetoclax and Azacitadine (VEN/AZA) in Adults with Previously Untreated CD123+ Acute Myeloid Leukemia (AML) who are Ineligible for Intensive Chemotherapy Read more
Effect of Adding Venetoclax to Intensive Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia Read more
Genotypic signatures of response to Venetoclax and Hypomethylating agent in treatment naive Acute Myeloid Leukemia and Myelodysplastic Syndrome Read more
Phase I Multicenter, Open-Label, First-in-Human Study Of ORM 6151 in Subjects With Relapsed Or Refractory Acute Myeloid Leukemia Or Myelodysplastic Syndrome-Increased Blasts 2 Read more
Impact of Clonal Hematopoiesis of Undetermined Potential (CHIP) Mutations on Engraftment Kinetics After Autologous Stem Cell Transplantation in Multiple Myeloma Read more
